Shaibal Chandra | Pharmacology | Editorial Board Member

Published on by Cell Biologist

Mr. Shaibal Chandra | Pharmacology | Editorial Board Member

Bengal School of Technology | India

Shaibal Chandra is an Assistant Professor of Pharmacology with strong academic training and research expertise in experimental and translational pharmacology. His teaching portfolio spans core and advanced subjects including Pharmacology, Human Anatomy and Physiology, Pathophysiology, Microbiology, Advanced Pharmacology, and Pharmaceutical Screening Methodology. His research interests focus on phytopharmacology, antioxidant and antiurolithiatic studies, CNS pharmacology, antifertility activity, immunopharmacology, and nano-based therapeutic approaches. He has conducted in vivo pharmacological evaluations using established animal models and possesses hands-on expertise in animal handling, biochemical assays, microscopic techniques, and laboratory instrumentation. His postgraduate research investigated the antiurolithiatic potential of metformin in ethylene glycol-induced renal stone models. He has authored multiple peer-reviewed research and review articles in national and international journals, contributed book chapters published by reputed academic publishers, and holds a published patent related to green nanoparticle synthesis with antioxidant and antibacterial applications. He actively participates in national and international scientific conferences through poster and e-poster presentations, including work on cancer immunotherapy and nanostructure-based drug delivery. He has also served as a reviewer for international journals and supervised undergraduate and postgraduate research projects, reflecting sustained engagement in academic research and mentorship.

Profile: Orcid

Featured Publications:

Chandra, S., & Chowdhury, S. (2025). Systemic effect of different physiological parameters associated with mirror syndrome. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70062

Chandra, S., Mondal, N., Chatterjee, A., & Tapadar, D. (2025). Exploration of antiurolithiatic properties of methanolic extract of rhizome of Cyperus tegetum Roxb. in ethylene glycol-induced urolithiatic rats. Pharmacological Research – Natural Products, 100181. https://doi.org/10.1016/j.prenap.2025.100181

Chandra, S. (2024). Phytochemical and pharmacological (CNS) screening of alcoholic extract obtained from Melia azedarach (leaf). Bengal School of Technology (A College of Pharmacy).

Kar, D. R., Dutta, A., Chandra, S., Das, P. P., & Paul, D. K. (2023). Evaluation of the antifertility activity of methanolic extract of Melia azedarach and their GC–MS study. International Journal of Pharmaceutical and Phytopharmacological Research, 13, 201–220. https://doi.org/10.51847/bxeo6u8vnk

Chakraborty, M., Das, P. P., Chandra, S., Shaharyar, M. A., Sarkar, N., Mukherjee, S., Paul, S., Bhowmik, R., Haldar, P. K., & Karmakar, S. (2023). Toxicology of nanoformulations and materials in tissue engineering. In Nanostructured materials for tissue engineering. Elsevier. https://doi.org/10.1016/B978-0-323-95134-0.00006-7

Chandra, S. (2023). Antidiabetic activity of exotic Indian spices. In Medicinal spices and herbs from India. Apple Academic Press (CRC Press).

Hamidreza Mohammadi | Toxicology and Pharmacology | Best Researcher Award

Published on by Cell Biologist

Prof. Hamidreza Mohammadi | Toxicology and Pharmacology | Best Researcher Award

Mazandaran University of Medical Sciences, Sari, Iran

Dr. Hamidreza Mohammadi is a researcher specializing in toxicology, pharmacology, and nanomedicine, with extensive work focused on the toxicological and therapeutic applications of nanomaterials. His research spans multiple domains including nanotoxicology, polymer therapeutics, clinical and food toxicology, and the development of safer nanopharmaceuticals. He has contributed to advancing the understanding of how engineered nanomaterials interact with biological systems, emphasizing risk assessment, cellular mechanisms of toxicity, and strategies for biocompatibility improvement. Dr. Mohammadi’s studies also explore the design of polymer-based drug delivery systems with enhanced therapeutic efficacy and reduced side effects. His work integrates experimental and applied toxicology to bridge laboratory research with clinical practice, contributing to public health and safety in pharmacological sciences. With interdisciplinary expertise covering both environmental and clinical toxicology, his research aligns with global priorities in nanomedicine innovation and toxicological risk evaluation. His scholarly efforts continue to support the development of next-generation nanotherapeutics with optimized pharmacokinetics and minimized toxic responses, reinforcing the importance of safe and sustainable nanotechnology in medical and pharmaceutical applications.

Profile: Orcid

Featured Publications:

Mokhtari Azad, T., Mohammadi, H., Moosavi, A., Saadatmand, Z., & Nategh, R. (2004). Influenza surveillance in the Islamic Republic of Iran from 1991 to 2001. Eastern Mediterranean Health Journal, 10(3), 315–321.

Cheraghali, A. M., Mohammadi, H. R., Amirahmadi, M., Yazdanpanah, H., Abouhossain, G., & Zamanian, F. (2005). Incidence of patulin contamination in apple juice produced in Iran. Food Control, 16(2), 165–167.

Shafiee, H., Mohammadi, H., Rezayat, S. M., Hosseini, A., Baeeri, M., & Hassani, S. (2010). Prevention of malathion-induced depletion of cardiac cells mitochondrial energy and free radical damage by a magnetic magnesium-carrying nanoparticle. Toxicology Mechanisms and Methods, 20(9), 538–543.

Mohammadi, H., Karimi, G., Rezayat, S. M., Reza, A., Shafiee, H., & Nikfar, S. (2011). Benefit of nanocarrier of magnetic magnesium in rat malathion-induced toxicity and cardiac failure using non-invasive monitoring of electrocardiogram and blood pressure. Toxicology and Industrial Health, 27(5), 417–429.

Soltani, M., Shetab-Boushehri, S. F., Mohammadi, H., & Shetab-Boushehri, S. V. (2013). Proposing boric acid as an antidote for aluminium phosphide poisoning by investigation of the chemical reaction between boric acid and phosphine. Journal of Medical Hypotheses and Ideas, 7(1), 21–24.